Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6–59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons. Issue 51 (3rd December 2020)

• Record Type: Journal Article
• Authors: Zhang, Wanqing; Gao, Junmei; Chen, Liling; Tian, Jianmei; Biggerstaff, Matthew; Zhou, Suizan; Situ, Sujian; Wang, Yin; Zhang, Jun; Millman, Alexander J.; Greene, Carolyn M.; Zhang, Tao; Zhao, Genming
• Is Part Of: Vaccine. Volume 38:Issue 51(2020)
• Page Start: 8200
• Page End: 8205
• Publication Date: 2020-12-03
• Subjects: Influenza vaccination -- Children -- Averted outcomes -- Hospitalization -- Influenza illness -- Medically attended; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2020.10.069
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: Influenza vaccine averted influenza-associated illnesses even with low coverage. Influenza vaccination prevented 6.2% influenza hospitalizations in Suzhou, China. Influenza vaccination prevented 6.5% influenza illnesses in Suzhou, China. Abstract: Background: There are few estimates of vaccination-averted influenza-associated illnesses in China. Methods: We used a mathematical model and Monte Carlo algorithm to estimate numbers and 95% confidence intervals (CI) of influenza-associated outcomes (hospitalization, illness, and medically-attended (MA) illness) averted by vaccination among children aged 6–59 months in Suzhou from October 2011–September 2016. Influenza illnesses included non-hospitalized MA influenza illnesses and non-MA influenza illnesses. The numbers of influenza-associated outcomes averted by vaccination were the difference between the expected burden if there were no vaccination given and the observed burden with vaccination. The model incorporated the disease burden estimated based on surveillance data from Suzhou University Affiliated Children's Hospital (SCH) and data from health utilization surveys conducted in the catchment area of SCH, age-specific estimates of influenza vaccination coverage in Suzhou from the Expanded Program on Immunization database, and influenza vaccine effectiveness estimates from previous publications. Averted influenza estimations were presented as absolute numbers and in terms of the prevented fraction (PF). A hypothetical scenario with 50% coverage (but identical vaccine effectiveness) over the study period was also modeled. Results: In ~250, 000 children, influenza vaccination prevented an estimated 731 (CI: 549–960) influenza hospitalizations (PF: 6.2% of expected, CI: 5.8–6.6%) and 10, 024 (7593–12, 937) influenza illnesses (PF: 6.5%, 6.4–6.7%), of which 8342 (6338–10, 768) were MA (PF: 6.6%, 6.4–6.7%) from 2011 to 2016. The PFs declined each year along with decreasing influenza vaccination coverage. If 50% of the study population had been vaccinated over time, the estimated numbers of averted cases during the study period would have been 4059 (3120–5762) influenza hospitalizations (PF: 27.2%, 26.4–27.9%) and 56, 215 (42, 925–78, 849) influenza illnesses (PF: 28.5%, 28.3–28.7%), of which 46, 596 (35, 662–65, 234) would be MA (PF: 28.5%, 28.3–28.7%). Conclusion: Influenza vaccination is estimated to have averted influenza-associated illness outcomes even with low coverage in children aged 6–59 months in Suzhou. Increasing influenza vaccination coverage in this population could further reduce illnesses and hospitalizations.